For the latter category, they concluded that there was "4no proof that overnutrition leads to arteriosclerosis in man," that "the available studies certainly discredit the theory that a high protein or meat diet is responsible for arteriosclerosis in man,' that "statements that fat is responsible for arteriosclerosis are not lacking in the literature, but these statements are not based upon controlled observations," and that "there is no positive or negative information that alterations in the inorganic elements of the diet or that disturbances in the metabolism of salts enhance the development of arteriosclerosis."
This negative approach to the scientific evidence linking diet and arteriosclerosis obviously was not shared by all. Rudolf Virchow,2 the founder of cellular pathology, had in the mid 19th century expounded his theory that the arterial wall imbibed substances from blood passing through it, leading to reactive degenerative changes that included a fatty metamorphosis of connective tissue cells. In 1925, Mjassnikow3 of Leningrad observed not only that patients with aortic and coronary arteriosclerosis often had high blood levels of cholesterol but that these levels might be reduced by diets in which vegetables were the chief foodstuffs. Professor Nikolai Anitschkow,4 also of Leningrad, performed *Part I of this article, on nutritional, infectious, and alcoholic heart disease, appeared in the June issue of Circulation.
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From Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts. Address for correspondence: Oglesby Paul, MD, Harvard Medical School, Countway Library of Medicine, 10 Shattuck Street, Boston, MA 02115. numerous investigations on rabbits and was able to produce lesions similar to those of human atherosclerosis by feeding cholesterol dissolved in vegetable oil. He wrote in 1933 that "atherosclerosis is not essentially of degenerative nature but rather of an infiltrative character," and, like Virchow, that "there is also under normal conditions a constant stream of liquid passing through the walls of the arteries in the direction from the lumen to the adventitia, " and that "from the morphological point of view arterial cholesterol atherosclerosis in rabbits is in many respects analogous to human atherosclerosis." Indeed, he later described "the two processes as analogous in all essential respects" and believed his findings to A fellow Bostonian and vigorous clinical investigator, Elliott P. Joslin6 had written a few years earlier a broad indictment not of cholesterol but of fats in relation to diabetes and arteriosclerosis:
I believe the chief cause of premature development of arteriosclerosis in diabetes, save for advancing age, is due to an excess of fat, an excess of fat in the body, obesity, an excess of fat in the diet, and an excess of fat in the blood.
In mentioning obesity, he was echoing the long-held view that it was deleterious-an impression documented by Dublin7 in 1931 in a classic publication based upon life insurance data that revealed an excess of deaths for circulatory disease, strokes, nephritis, and diabetes in overweight male policyholders above that seen in individuals of "normal" weight.
A leading investigator in this whole area was Ancel Keys of the University of Minnesota. After 15 years of varied basic physiologic studies, Keys in 1948 began to publish with his colleagues the results of metabolic and epidemiologic observations relating diet to atherosclerotic disease. He early emphasized that prevention through dietary means might best be achieved through "less rather than more"8; and although there was an important relation between atherosclerosis and the serum cholesterol level, he stressed in 1950 that the "blood cholesterol level is independent of the intake [of cholesterol] over a wide range." Indeed, he wrote that "it is doubtful whether most so-called low cholesterol diets in current use reach critical levels or have significant utility."9 In 1952, he concluded, much like Joslin, that "4a substantial measure of control of the development of atherosclerosis in man may be achieved by control of the intake of calories and of all kinds of fats with no special attention to the cholesterol intake. " , and other population testaments to the hazards of both systolic and diastolic hypertension for the brain, heart, and kidneys. Specifically, the data showed an increased death rate from cardiovascular and renal causes with levels of systolic and diastolic pressure initially considered benign, with a progressively increasing mortality the higher the values found. Further, although the correlation of hypertension and deaths from strokes was obvious relatively early, it also became apparent starting with the uncontrolled observations of Allan21 in 1934 that "hypertension should be considered a major factor in the etiology of both angina pectoris and coronary occlusion."
A first step in the prevention of morbidity and mortality from hypertension could be a reduction in its amount and severity. As with rheumatic fever, such a favorable (and unexplained) change actually began well before specific measures of intervention were developed. Starting in 1940, death rates in the United States for hypertensive disease (and cerebrovascular diseases) began to decline substantially for white men and women in all adult age groups and to a lesser extent for nonwhite individuals.22 Similar declines were seen in other countries, chiefly those with high initial rates.
The eventual development of efforts to prevent the complications of hypertension-stroke, heart attack, and renal vascular disease-emphasized both recognition of the presence of high blood pressure in the individual and of its treatment. There was some early concern that the new gadget, the sphygmomanometer, was being used too often, and the findings served only to frighten the patient. This was true even though the pioneer insurance company data had shown the value of the casual office blood pressure reading as a guide to potential cardiovascular disease. However, Sir Thomas Lewis23 wrote in 1937, Patients in whom high blood pressure is found should rarely be informed of the fact . .. The habit of following blood pressure by frequent readings during treatment and of allowing patients access to such readings is strongly to be deprecated. The patient becomes obsessed by blood pressure, and the manometer is regarded as the gauge of health. 23 The importance of the casual blood pressure for the physician and the patient of course was enhanced when effective pharmacotherapy became available. The third aspect was that of primary prevention, the last to be confronted and the least to be documented in terms of scientific data. As noted above, there was good evidence that, for obscure reasons, deaths from hypertensive diseases and strokes began to decline in the United States in incidence about or before 1940. This trend, and with it a reduction in deaths from coronary heart disease, has continued, in part at least attributable to the increasing pace of recognition and treatment of high blood pressure by the medical and allied health professions. There is no evidence that national changes in salt or alcohol intake, or reductions in body weight, have contributed to this process. It However, there were no consistent changes in diastolic pressure during the same time frame, and the overall age-adjusted proportion of adults with elevated blood pressure (systolic pressures equal to or greater than 140 mm Hg or diastolic pressures equal to or greater than 90 mm Hg) was essentially the same.
The international data on mortality trends in hypertension and its complications do not show universal improvement. However, as Rose32 has commented, international "trend data on blood pressure are so weak that we are driven to use stroke mortality as a proxy," and "the decline in stroke mortality is unfortunately by no means universal."
Primary prevention may be taking place in some countries, including the United States where both stroke and coronary disease mortality have fallen sharply. This is probably partly with a targeted intervention approach and partly without.
Exercise
The role of physical exercise in the management and prevention of cardiovascular disease has been controversial until recent decades. A review of some of the older literature shows views that are decidedly contrasting.
In 1879, J.M. Fothergill33 of London published The Heart and Its Diseases, With Their Treatment: Including the Gouty Heart. Although he, like most authors, did not address the role of exercise in prevention, he wrote, "Rest is of the greatest value in all forms of organic disease of the heart," and "If a man with a diseased heart follows a laborious employment, he must be counselled to abandon it for a less trying one." Also, in reference to early stages of disease, he wrote, "it is only necessary to economize the body-forces, by diminished exertion, the avoidance of all causes Typical of the attitude of less distinguished medical minds, and of lay men and women, were the following quotations from a book36 on the heart published in 1934 and intended to educate the public:
Physical strain is likely to induce serious damage in an adolescent heart. Overindulgence in tennis, swimming and wrestling, may so stress the heart that the valve leaflets fail to approximate and a functional murmur results. Repeated physical overstrain aggravates the heart condition and persistent striving in sports will lay a foundation for the athletic type of heart which thereafter is never again fully efficient when at rest . The relation between heart disease and the smoking habit was confirmed more slowly. A brief paper by Pearl54 appeared in 1938 based upon observation of 6,813 men, observations which were only sketchily described. He concluded that "the smoking of tobacco was statistically associated with an impairment of life duration, and the amount or degree of this impairment increased as the habitual amount of smoking increased." Specific reference to coronary heart disease and smoking (nearly all of cigarettes) was first made by English, Willius, and Berkson55 of the Mayo Clinic in 1940, who reviewed the clinic records of 1,000 men aged 40 years and over with a diagnosis of angina pectoris, or recent or old myocardial infarction, and they compared these with the records of 1,000 age-matched men without evident coronary heart disease. These investigators showed both more smokers among the younger (aged 40-49 years) of their coronary cases than among the control subjects and a positive relation of the incidence of clinical coronary disease to the amount of smoking. It is interesting to read the comments of the four discussors when this was first presented. Two of them were clearly skeptical, one distinguished professor (who was one of my teachers) saying that the history of smoking "does not justify a conclusion that the smoking per se is a causative or even a contributory agent of coronary disease." Of course, at that time, the concept of smoking as a risk factor for heart disease was new, and the amount of data was retrospective and limited.
The first impressive documentation of the hazards of smoking for the heart was the unexpected by-product of a major prospective epidemiologic study of the American Cancer Society organized by Hammond and Horn. This investigation was intended to document the relation between smoking habits and lung cancer death rates as well as with overall death rates. A four-page smoking questionnaire was developed in 1951, and over 22,000 volunteers were recruited and trained to administer it annually to men initially aged 50 to 69 years. Follow-up included examination of death certificates. In 1954, Hammond and Horn56 reported on 187,766 men in the study, 4,854 of whom had died. Disease of the coronary arteries was listed as the cause of death in 46% of the deaths, and it was found that the death rates from coronary heart disease in the age group of 50 to 25 were heavy smokers, concluded somewhat reluctantly that the tobacco habit must play an important causative role. A study of patients with thrombo-angiitis obliterans reported by Weber60 in 1916 included the finding that "in nearly every case there is a history of habitual cigarette smoking, and in some cases the patients, owing to being employed in cigarette factories, have been able to smoke large numbers of cigarettes daily without paying for them." Despite this evidence, he concluded that "it is extremely improbable that the cigarette smoking is more than a contributory factor in inducing the disease." By 1928, however, Brown and Allen6' writing about thrombo-angiitis obliterans on the basis of extensive experience at the Mayo Clinic concluded that in regard to smoking, "there is sufficient evidence to interdict its use during any stage of the disease." Similar recommendations by Allen, Barker, and Hines62 for individuals with peripheral arteriosclerotic disease followed soon thereafter.
It was clear at the outset that mounting an effective program against smoking would not be easy, especially when the habit was so widespread among physicians. Older physicians well remember scientific meetings during the 1940s and 1950s, and later, when the air in conference rooms was literally blue with smoke, the dense haze being penetrated by the bright beam from the projection lantern. In 1956, the American Heart Association issued its first cautious statement on the relation between heart disease and smoking, and this was followed in 1960 by a somewhat stronger version.63 On February 27, 1960 Comment Thus, the record of achievements in the prevention of cardiovascular disease is more than respectable. It is impressive. During the past 100 years, at least 11 causes of important heart disease have been studied and treated and to a variable extent prevented. These successes represent the fruits of international efforts by scientists from many disciplines. In eight of the areas-rheumatic fever, diphtheria, syphilis, alcohol, diet, hypertension, physical exercise, and smoking-the achievements reflect contributions made by many individuals during a considerable passage of time. In three areas-beriberi, rubella, and cobalt-a breakthrough leading to prevention came rapidly, the results of a few inquiring minds and keen observations. Today, significant problems remain with regard to rheumatic fever, syphilis, alcohol, diet, hypertension, physical exercise, and smoking, which are problems existing as much from needs in education, socioeconomic issues, and difficulties in changing human habits as from deficiencies in scientific knowledge. As is well known, it is easier to prevent with a vaccine or pill or simple dietary modification than to persuade individuals to alter life-long customs. Further, we probably have not recognized all the potentially correctable influences unfavorable for the cardiovascular system. However, the record of the past century and the escalating pace of scientific knowledge are favorable for an ultimately more complete success in prevention than is present today. We must be sure, however, as technology changes our environment, that we do not introduce new factors, like cobalt, which will in turn require their own identification and elimination.
Summary
The prevention of cardiovascular disease antedates our current preoccupation with risk factors for coronary heart disease and hypertension. Indeed, earlier preventive efforts have in part been so successful that many people have forgotten that they existed. The almost forgotten entity, beriberi heart disease, was first prevented in 1883 by Takaki of Japan. With diphtheria, it was the identification of the causative bacillus by Klebs in 1883, leading finally to the development of diphtheria toxoid by Ramon in 1923, which resulted in the disappearance of diphtheritic heart disease. Success in the attack on syphilitic heart and vascular disease began with Bordet and Gengou in 1901 with the discovery of the phenomenon of complement fixation, and with the formulation of Salvarsan by Ehrlich in 1907. The story of the prevention of rheumatic fever has a large cast of characters, but special recognition must be given to Coburn for his observations confirming the role of the hemolytic streptococcus published in 1931 and showing the prophylactic value of sulfanilamide published in 1939. The important association of maternal rubella with congenital heart malformations was revealed by Gregg in 1941. Alcoholic heart disease was identified particularly by Brigden and Evans in 1957 and 1959, respectively. In relation to coronary and hypertensive heart disease, the names of Anitschkow (1933) , Leary (1935) , and Keys (1948) in relation to diet, of Freis (1967) in the field of hypertension treatment, of White (1927) 
